{
    "eid": "2-s2.0-85137387060",
    "title": "Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents",
    "cover-date": "2022-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "adolescents",
        "BNT162b2",
        "immune response",
        "liver transplant",
        "vaccine"
    ],
    "authors": [
        "Palittiya Sintusek",
        "Supranee Buranapraditkun",
        "Siriporn Khunsri",
        "Varattaya Saengchaisukhonkit",
        "Preeyaporn Vichaiwattana",
        "Donchida Srimuan",
        "Thanunrat Thongmee",
        "Yong Poovorawan"
    ],
    "citedby-count": 2,
    "ref-count": 31,
    "ref-list": [
        "Presumed Asymptomatic Carrier Transmission of COVID-19",
        "Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine",
        "COVID-19 and the liver: A 2021 update",
        "EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients",
        "Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022",
        "Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults",
        "Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine",
        "Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients",
        "Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients",
        "Humoral Response to SARS-CoV-2 Vaccination in Liver Transplant Recipients\u2013A Single-Center Experience",
        "Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients",
        "Antibody response to 2-dose SARS-CoV-2 mRNA vaccination in pediatric solid organ transplant recipients",
        "Immunological mechanisms of vaccine-induced protection against COVID-19 in humans",
        "Broadly neutralizing hemagglutinin stalk\u2013specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo",
        "Nonneutralizing functional antibodies: A new \u201cold\u201d paradigm for HIV vaccines",
        "Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study",
        "SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European Experience",
        "Updates from the NASPGHAN/SPLIT SARS-CoV2 International Registry",
        "Safety, Immunogenicity, and Efficacy of the BNT162b2 COVID-19 Vaccine in Adolescents",
        "Liver injury following SARS-CoV-2 vaccination: A multicenter case series",
        "Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient",
        "Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: An Israeli population-based study",
        "Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality",
        "Vitamin D and Inflammation: Potential Implications for Severity of COVID-19",
        "Does Vitamin D Deficiency Affect the Immunogenic Responses to Influenza Vaccination? A Systematic Review and Meta-Analysis",
        "Putative Role of Vitamin D for COVID-19 Vaccination",
        "Tixagevimab + Cilgavimab: First approval",
        "Nanocarrier vaccines for SARS-CoV-2"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "National Research Council of Thailand and Thai Pediatric Gastroenterology, Hepatology and Immunology",
        "TPGHAI",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "Health Systems Research Institute"
    ]
}